---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-019025"
form_type: "8-K"
ticker: "CLNN"
cik: "0001822791"
company_name: "Clene Inc."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T14:15:08.670360+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Clene amends loan with Avenue, extends interest-only period, issues 3M share warrant at $0.80

## Summary
- Interest-only period extended to June 2024 contingent on $35M equity raise; further to Dec 2024 on additional $40M and FDA ALS NDA acceptance.
- Maturity may extend from Dec 2024 to Dec 2025 if both equity milestone 2 and ALS NDA milestone are met.
- New warrant to purchase 3M shares at $0.80 (expires June 2028) replaces old warrant; cash or cashless exercise.
- Company expects $35M equity raise closed June 21 satisfies first milestone for interest-only extension.
- Updated corporate presentation posted on website; future updates may only be disseminated via website.

## SEC filing metadata
- accession: 0001437749-23-019025
- form_type: 8-K
- ticker: CLNN
- cik: 0001822791
- company_name: Clene Inc.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822791/000143774923019025/0001437749-23-019025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822791/000143774923019025/clnn20230622_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-019025
- JSON: https://secwatch.observer/filing/0001437749-23-019025.json
- Plain text: https://secwatch.observer/filing/0001437749-23-019025.txt

## Key facts
- Material Agreements
  Clene Inc. amended Second Amendment to Supplement to Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P. valued at Amendment extends interest-only period to June 30, 2024 (subject to $35M equity milestone) or Decemb (effective 2023-06-27).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Avenue Venture Opportunities Fund, L.P.
  - Value: Amendment extends interest-only period to June 30, 2024 (subject to $35M equity milestone) or Decemb
  - Effective: 2023-06-27
  source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On June 27, 2023 (the “Effective Date”) , Clene Inc. and its wholly owned subsidiary, Clene Nanomedicine, Inc. (together with Clene Inc. and its other subsidiaries, the “Company”), entered into the Second Amendment to Supplement to Loan and Security Agreement (the “Second Amendment”) by and among Avenue Venture Opportunities Fund, L.P. (“Avenue”) and the Company. The Company originally entered into the Loan and Security Agreement (the “Loan”) with Avenue on May 21, 2021. Pursuant to the Second Amendment, the interest-only period of the Loan may be extended (i) through June 30, 2024, subject to the Company’s receipt of at least thirty-five million dollars ($35,000,000) in June 2023 from the sale and issuance of the Company’s equity securi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822791/000143774923019025/0001437749-23-019025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.